Trials / Terminated
TerminatedNCT02518568
Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia
Study of the Pharmacokinetics of Serum Iron After a Single Oral Administration of Ferrous Sulphate Supplement Synthetic Formula in Women With Iron Deficiency Anaemia.
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the pharmacokinetics of serum iron after a single oral administration of 160 mg (2 tablets of 80 mg) V0355 in women with iron deficiency anaemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | V0355 | Oral administration (2 tablets) |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-08-10
- Last updated
- 2016-09-28
Locations
2 sites across 2 countries: Bulgaria, Romania
Source: ClinicalTrials.gov record NCT02518568. Inclusion in this directory is not an endorsement.